Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 13 September, 2018

Competition and Mkts

Merger Update - Replacement text

RNS Number : 7196A
Competition and Markets Authority
13 September 2018
 

 

 

 

 

Replacement text

 

The following replaces the Merger Update announcement released today 13 September 2018 at 12:00 under RNS number 6870A. The full amended text appears below:

Anticipated acquisition by CME Group of NEX Group

Invitation to comment: Closes on 27 September 2018.

 

The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.

To assist it with this assessment, the CMA invites comments on the transaction from any interested party. These comments should be provided by the deadline set out below to:

Case officer name: Nick Wright

Tel no: 0203 738 6791

E-mail: [email protected]

Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please see our Privacy Notice.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MERFKNDPDBKDNCD

a d v e r t i s e m e n t